Forest Pharmaceuticals recalls

Forest Pharmaceuticals has 6 recalls on record with the FDA and USDA, the earliest in 2014 and the latest reported on 29 Oct 2014. The most frequent reason is potency & assay.

Total recalls6since 2014

Last 12 months0reported

Class I00% of total

Ongoing0latest 29 Oct 2014

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 50%Class III 3 50%

Why forest pharmaceuticals is recalled

Potency & Assay6100%

Product types

Blood Pressure Medication350%

By year

20146100%

All forest pharmaceuticals recalls, newest first

6 total

Reported	Class	Recall	Company	Reason	Where
29 Oct 2014Drug	CLASS II	Bystolic (nebivolol) tablets, 20 mg/tablet recalled	Forest Pharmaceuticals	Potency & Assay	Nationwide
9 Jul 2014Drug	CLASS II	Bystolic (nebivolol) tablets, 20 mg/tablet recalled	Forest Pharmaceuticals	Potency & Assay	Nationwide
28 May 2014Drug	CLASS II	Bystolic (nebivolol), 20 mg/tablet recalled by Forest PharmaceuticalsBystolic	Forest Pharmaceuticals	Potency & Assay	Nationwide
12 Feb 2014Drug	CLASS III	Namenda XR (memantine HCl), titration pack (7 mg, 14 mg recalled	Forest Pharmaceuticals	Potency & Assay	Nationwide
12 Feb 2014Drug	CLASS III	Namenda XR (memantine HCl), sample pack, 28 mg recalled	Forest Pharmaceuticals	Potency & Assay	Nationwide
12 Feb 2014Drug	CLASS III	Namenda XR (memantine HCl) recalled by Forest Pharmaceuticals	Forest Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.